News
SILK
18.32
-2.08%
-0.39
Weekly Report: what happened at SILK last week (0318-0322)?
Weekly Report · 4d ago
Silk Road Medical (SILK) Upgraded to Buy: What Does It Mean for the Stock?
NASDAQ · 6d ago
Weekly Report: what happened at SILK last week (0311-0315)?
Weekly Report · 03/18 09:01
Analysts Are Bullish on Top Healthcare Stocks: Silk Road Medical (SILK), Arcellx Inc (ACLX)
TipRanks · 03/14 12:40
Have Silk Road Medical Insiders Been Selling Stock?
Silk Road Medical, Inc's (NASDAQ:SILK) CFO & COO recently sold US$170k worth of stock at US$17.17 per share. This is the biggest insider sale in the last year. In the last decade, Silk Road Medical insiders haven't bought any stock. The company owns 2.1% of Silk Road medical. The sale of shares by Lucas Buchanan is only 6.0% of a company's share price. It's beneficial to know about insider transactions at Silk RoadMedical.
Simply Wall St · 03/09 12:53
Reported Earlier, Genesis MedTech Collaborates With Silk Road Medical To Combat Stroke Risk In China With Advanced TCAR Technology
Benzinga · 03/08 06:52
Argus upgrades Silk Road Medical to buy, cites expanding footprint
Healthcare Argus upgrades Silk Road Medical to buy, cites expanding footprint. The company is expanding its sales force and moving into markets such as China and Japan. Argus set its price target for the stock at $24, citing the company's efforts to expand its commercial footprint.
Seeking Alpha · 03/07 19:50
Silk Road Medical Price Target Announced at $24.00/Share by Argus Research
Dow Jones · 03/07 15:53
Silk Road Medical Raised to Buy From Hold by Argus Research
Dow Jones · 03/07 15:53
Thursday 3/7 Insider Buying Report: SLRC, SILK
NASDAQ · 03/07 15:47
Argus Research Upgrades Silk Road Medical to Buy, Announces $24 Price Target
Benzinga · 03/07 15:43
Silk Road Medical's (SILK) New Stent Expands Its TCAR Portfolio
NASDAQ · 03/07 12:52
Analysts’ Top Healthcare Picks: Semler Scientific (SMLR), Silk Road Medical (SILK)
TipRanks · 03/06 14:02
Silk Road Medical: Statement of changes in beneficial ownership of securities
Press release · 03/05 23:39
Breaking Down Silk Road Medical: 5 Analysts Share Their Views
Silk Road Medical is a medical device company focused on reducing the risk of stroke. The company has an average 12-month price target of $20.0. Silk Road Medical underwent analysis by 5 analysts in the last quarter. The firm has a positive revenue growth rate of 18.89% over the past three years.
Benzinga · 02/29 21:00
Silk Road Medical Price Target Raised to $23.00/Share From $20.00 by Stifel
Dow Jones · 02/29 17:53
Silk Road Medical Is Maintained at Buy by Stifel
Dow Jones · 02/29 17:53
Stifel Maintains Buy on Silk Road Medical, Raises Price Target to $23
Benzinga · 02/29 17:42
Silk Road Medical Is Maintained at Neutral by JP Morgan
Dow Jones · 02/29 16:40
Silk Road Medical Price Target Raised to $19.00/Share From $10.00 by JP Morgan
Dow Jones · 02/29 16:40
More
Webull provides a variety of real-time SILK stock news. You can receive the latest news about Silk Road Medical through multiple platforms. This information may help you make smarter investment decisions.
About SILK
Silk Road Medical, Inc. is a medical device company that is focused on reducing the risk of stroke and its impact. The Company has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. It manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.